Related Experiment Video
Updated: Jan 15, 2026

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
Differences in Imaging Findings Between Benign and Borderline Ovarian Serous/Mucous Tumors
Ailing Xu1,2,3,4, Fang Nie1,2,3,4, Luping Liu1,2,3,4
1Ultrasound Medical Center, The Second Hospital of Lanzhou University, Lanzhou, China.
Objectives:
To retrospectively analyze the differences in imaging findings between benign and borderline ovarian serous/mucous tumors.
Methods:
Imaging features of benign and borderline ovarian tumors were analyzed, including the tumor maximum diameter, laterality, tumor morphology, proportion of solid components, and the number of papillary processes in cystic solid tumors.
Results:
A total of 189 tumors were evaluated, including 117 benign tumors and 72 borderline tumors. The mean maximum diameter of borderline tumors was higher than that of benign tumors (14.32 ± 9.93 vs. 8.62 ± 6.69, p < 0.05). Borderline tumors with solid components accounted for more than benign tumors (41.67% vs. 8.55%). The proportion of solid component volume/tumor volume > 15% in both benign and borderline tumors was very small (1.71%, 4.71%). In unilocular cysts and multilocular cysts, borderline tumors with diameters > 10 cm accounted for more than benign tumors. The sensitivity and specificity in distinguishing benign and borderline tumors of ultrasonography O-RADS are slightly lower than those of SR of IOTA (86.1% vs. 91.7%, 81.2% vs. 82.1%).
Conclusions:
In conclusion, the borderline tumors are larger and have more solid components than the benign tumors. The sensitivity and specificity in distinguishing benign and borderline tumors of ultrasonography O-RADS are slightly lower than those of SR of IOTA.
More Related Videos
08:09Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010